Bank of America 13F: Cuts Albemarle (ALB) Stake by $5.5M
Bank of America reduced its holdings in specialty chemicals maker Albemarle Corporation by 33,986 shares during the period.
Reviewed by automated data checks against the source filing. How we make and check alerts
Bank of America sold 33,986 shares from its stake in Albemarle Corporation ($ALB), a 1.13% decrease, according to a 13F filing with the SEC dated May 18, 2026. It reported 2,976,335 shares worth $482.32 million at the end of the quarter.
Since the filing, $ALB is down 0.6% after 1 week, down 5.0% after 1 month and down 45.4% to date (from the $174.70 close on May 18, 2026).
Key Points
- Bank of America trimmed its stake in Albemarle Corporation (NYSE: ALB) by 1.1% in its recent SEC filing, selling 33,986 shares.
- The institution ended the reporting period with 2,976,335 shares of the specialty chemicals producer, valued at approximately $482.3 million.
- Albemarle trades near $162.05 with a forward P/E of 10.0, while analysts maintain a consensus Buy rating and a mean price target of $171.56.
Get $ALB trade alerts by text
We text you when insiders, Congress or big funds trade $ALB. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Albemarle Corporation alert may contain errors. Disclosures
Bank of America reduced its holdings in Albemarle Corporation (NYSE: ALB) during the reporting period, trimming its stake by 33,986 shares according to a recent Form 13F filing with the SEC. Institutional filings like this one look backward at a prior period and may not represent the investor's current holdings.
Position Details and Share Count
The adjustment lowered Bank of America's position by a 1.1% reduction from the previous quarter. The bank went from holding 3,010,321 shares down to 2,976,335 shares. Based on market values around the filing period, the remaining stake is worth roughly $482.3 million.
Albemarle Stock Performance and Valuation
Albemarle shares trade around $162.05, sitting above its 50-day moving average of $125.08 and near its 200-day moving average of $156.26. The stock has seen a 52-week low of $79.30 and a high of $221.00. The company carries a forward P/E ratio of 10.0 and a trailing P/E of 418.22.
Recent Earnings Results
For its recent operational period, Albemarle posted $5.91 billion in revenue with a revenue growth rate of 31.1%. The company recorded earnings per share of $0.27, alongside a net margin of 3.8% and a return on equity of 2.6%. The company's next earnings report is scheduled for November 4, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
8 analysts raised price targets.
-
EPS & revenue
EPS beat estimates by 166.8%. Revenue beat estimates by 7.2%.
-
Profit surprise
EBITDA missed by 36 percent. Operating income beat by 41 percent.
-
Pre-earnings setup
Expectations were about average.
-
Analyst signal
8 target raises.
-
Earnings quality
Gross margin up 20.7 points. Operating margin up 14.7 points. Positive free cash flow.
Earnings Call Summary
Albemarle had a strong first quarter with $1.43 billion in revenue, up 33 percent from last year, and $664 million in adjusted earnings, more than double the prior year. The company benefited from higher lithium prices (up 51 percent), increased volumes in Energy Storage of 14 percent, and successful cost cutting that saved $40 million so far this year. The company paid down $1.3 billion of debt, improving its financial flexibility, and generated $248 million in free cash flow in the quarter.
Guidance Management raised their full year outlook for the Specialties business, now expecting between $1.3 billion and $1.5 billion in sales and $225 million to $275 million in adjusted earnings. They kept their Energy Storage outlook unchanged despite supply chain disruptions from the Middle East, estimating the cost impact at $70 million to $90 million. The company expects to offset these costs through lower interest expense from debt paydown and better than expected Specialties pricing and volumes.
Good report. The company beat and showed some forward improvement, with a few meaningful caveats.
Dividend Payout
Albemarle pays an annual dividend rate of $1.64 per share, translating to a dividend yield of 1.5%. The payout ratio stands at 6.0%.
Analysts Set New Price Targets
Wall Street analysts maintain a consensus Buy rating on Albemarle, with a mean price target of $171.56 across 20 analyst opinions. Recent rating updates include RBC Capital maintaining an Outperform rating with a $129.00 price target on October 15, 2026. Mizuho maintained an Outperform rating with a $130.00 target on October 14, 2026, while Barclays initiated coverage with an Equal-Weight rating and a $109.00 target on October 13, 2026. Argus Research maintained a Buy rating with a $135.00 target on October 7, 2026, and UBS maintained a Buy rating with a $150.00 target on October 5, 2026.
About Albemarle Corporation
Headquartered in Charlotte, North Carolina, Albemarle Corporation operates as a specialty chemicals provider focused on lithium compounds for electric vehicle batteries, energy storage, bromine products for fire safety, and clean fuel catalysts. The company serves automotive, electronics, and energy markets worldwide.
What to Watch at ALB
Investors tracking Bank of America's equity shifts should look for subsequent SEC filings to see how the bank adjusts its major positions. Albemarle's upcoming earnings release on November 4, 2026, will offer fresh insight into its specialty chemicals and energy storage segments.
Source: Bank of America's 13F filing on $ALB (May 18, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Find the original filing: Bank of America 13F filings on SEC EDGAR. Written by software, not financial advice. How we make alerts
